INSIGHTS ON CLINICAL TRIAL DESIGN

• Leveraging Biomarkers In Early PK/PD Studies

  Integrating biomarkers into early clinical studies is crucial to determine whether a new therapy engages its biological target, triggers the intended PD effects, and shows early signs of efficacy.

• Overcoming Barriers To Participation

  Explore effective strategies to enhance diversity and inclusion in clinical trials by supporting underrepresented patient groups, ensuring equitable health outcomes and broader representation.

• In Search Of A Cure For Low Enrollment In Oncology Clinical Trials

  Delayed enrollment can cost oncology trials up to $250K per patient. Explore the barriers keeping patients out and practical ways to reach more of them faster.

• Reduction Of Screen Failures In A Biomarker

  Targeted prescreening for biomarker and cognitive criteria cut screen failures in a complex Alzheimer’s trial, speeding enrollment and improving site efficiency while maintaining strict eligibility.

• Yes, Your Study Is At Risk: Risk Mitigation Plans For Endpoints

  1/15/2026

  Ocular endpoints often introduce unique bottlenecks that can stall enrollment and compromise data integrity. This presentation provides the tools for a streamlined, resilient clinical trial strategy.

• Where Study Simulation Fits In Clinical Trials

  4/21/2026

  Simulation lets teams test assumptions early, showing how design and operations affect timelines, cost, and feasibility — reducing risk and enabling confident, data‑driven decisions.

• The Evolving Landscape Of Emerging Biopharma: Modern Trends And Flexible Trial Designs

  9/28/2026

  Running complex trials on a lean budget? See how adaptive designs, decentralized models, and early real-world evidence help emerging drug developers plan globally and get therapies to patients faster.

• 5 RWE Approaches That Strengthen Precision Oncology

  3/31/2026

  Real-world evidence is becoming vital in precision oncology. Discover five creative, practical ways sponsors can use RWE to fuel development, sharpen regulatory strategy, and strengthen market access.

• Reimagining Medical Monitoring In Clinical Research

  4/11/2025

  Clinical trials are undergoing a transformative shift driven by evolving regulations, advanced technologies, and decentralized methodologies.